In-car infotainment is a complete suite of advanced features that are integrated in cars to provide entertainment, information, connectivity, and communication services. Advanced infotainment systems facilitate Bluetooth, Wi- Fi connectivity, interactive voice recognition services, live media streaming, and smart technology for mobile integration. In-car Infotainment systems are offered by leading manufacturers such as Ford (SYNC and MyFord Touch), Toyota (Entune), Kia Motors (UVO), Cadillac (CUE), and Fiat (Blue&Me). This system in cars frequently utilize Bluetooth technology and/or smartphones to help drivers control the system with voice commands, touchscreen input, or physical controls.

Hydrogen fuel cell vehicle is a type of vehicle that uses a hydrogen fuel cell to power its on-board electric motor. This vehicle does not release any greenhouse gas (GHG) emissions during vehicle operation unlike diesel- powered and gasoline vehicles. Further, extensive support from the government to propel hydrogen fuel cell infrastructure fuels the market growth. The scope of hydrogen fuel cell vehicle report is derived from different vehicle types. The report includes a micro-level study of different regions that adopt hydrogen fuel cell vehicle for various vehicle types. In addition, it discusses the potential opportunities for market players to enter the market and provides an in-depth market analysis of hydrogen fuel cell vehicle, outlining current trends, key driving factors, and potential areas for product investments.

Immunosuppressants are the class of drugs that are prescribed to prevent rejection of transplanted tissues and organs and these are also widely used in the treatment of autoimmune disorders such as Crohn’s disease, arthritis. The report of the immunosuppressant market involves the study of different drug classes that work as immunosuppressants, including corticosteroids, monoclonal antibodies (mAbs), calcineurin inhibitors, mTOR inhibitors, and anti-proliferative agents. In addition, it covers the indications in which these drugs are used including organ transplantation, auto-immune disorders, and non-autoimmune inflammatory diseases. Moreover, this report provides a detailed analysis of the current market trends and future estimations from 2019 to 2026.